2
1 DAFTAR PUSTAKA Anonim. 2012. Standar Prosedur Operasional SMF Obstetri Ginekologi . Purwokerto : RSUD Prof. Dr. Margono Soekarjo. Asada, Hiromi. Yoshiaki Yamagata. 2008.  Potential Link Between Estrogen  Receptor-α gene hypomethilation amd uterine fibroid formation . Oxford : Oxford University Press. Baird, Donna Day, Greg Travios. 2009. Uterine Leiomyomata in Relation to  Insuline Like Growth Factor 1, Insulin, and Diabetes.  Washington DC : George Washington University Medical Center. Carbonell JL, Acosta R, Pérez Y, et al. 2013. Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial. Int J Womens Health. 5: 115   124.  Ciavattini, Andrea, Jacopo Di Giuseppe. 2013. Uterine Fibroids : Pathogenesis and Interaction with Endometrium and Endometrical Junction . Italia : University of Marche Eisinger SH, Fiscella J, Bonfiglio T, Meldrum S, Fiscella K. 2009. Open-label  study of ultra low-dose mifepristone for the treatment of uterine leiomyomata. Eur J Obstet Gynecol . 146(2):215   218. Esteve JL, Acosta R, Pérez Y, Campos R, Hernández AV, Texidó CS. 2011 Treatment of uterine myoma with 5 or 10 mg mifepristone daily during 6months, post-treatment evolution over 12 months: double-blind randomized clinical trial.  Eur J Obstet Gynecol Reprod Biol . ; 161(2):202   208. Faerstein, Eduardo, Moyses Szkio. 2013.  Risk Factors For Uterine Leiomyoma: A  Practice Based Case Control Study Atherogenic Risk Factors and Potential Sources of Uterine Leiomyomas. Amerika : American Journal of Epidemiology Fiscella K, Eisinger SH, Meldrum S, Feng C, Fisher SG, Guzick DS. 2006. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size. A randomized controlled trial. Obstet Gynecol.108(6): 1381   1387. Flake, G.P., J. Anderson, and D. Dixon. 2003. Etiology and Pathogenesis of Uterine Leiomyomas: a Review. Environmental Health Perspectives. 111 (8): 1037-1041. Hadibroto, Budi R. 2010.  Mioma Uteri. Medan : Departemen Obstetri dan Ginekologi FK USU. Jarrett, Renne Buynton, Janet Rich Edward. 2003.  A prospective study of  Hypertention and Risk of Uterine Leimyomata. Amerika : American Journal Of Epidemiology King, A.E., F. Collins, T. Klonisch, J.M. Sallenave, H.O.D. Critchley, and P.T.K. Saunders. 2010. An Additive Interaction between The NFκB and Estrogen Receptor Signaling Pathways in Human Endometrial Epithelial Cells. Human Reproduction. 25 (2):510-518 Medilcare, Veronicha, Lakshmi Rao. 2011. The Genetic Base Of Uterine Fibroid . India : Jreprod Infertil. Montgomery, B.E., G.S. Daum, and C.J. Dunton. 2004. Endometrial Hyperplasia: A Review. Obstetrical and Gynecological Survey. 59 (5): 368-378.

DAPUS

Embed Size (px)

DESCRIPTION

leiomyoma

Citation preview

DAFTAR PUSTAKAAnonim. 2012. Standar Prosedur Operasional SMF Obstetri Ginekologi. Purwokerto : RSUD Prof. Dr. Margono Soekarjo.Asada, Hiromi. Yoshiaki Yamagata. 2008. Potential Link Between Estrogen Receptor- gene hypomethilation amd uterine fibroid formation. Oxford : Oxford University Press.Baird, Donna Day, Greg Travios. 2009. Uterine Leiomyomata in Relation to Insuline Like Growth Factor 1, Insulin, and Diabetes. Washington DC : George Washington University Medical Center.Carbonell JL, Acosta R, Prez Y, et al. 2013. Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial. Int J Womens Health. 5: 115124.Ciavattini, Andrea, Jacopo Di Giuseppe. 2013. Uterine Fibroids : Pathogenesis and Interaction with Endometrium and Endometrical Junction. Italia : University of MarcheEisinger SH, Fiscella J, Bonfiglio T, Meldrum S, Fiscella K. 2009. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata. Eur J Obstet Gynecol. 146(2):215218.Esteve JL, Acosta R, Prez Y, Campos R, Hernndez AV, Texid CS. 2011 Treatment of uterine myoma with 5 or 10 mg mifepristone daily during 6months, post-treatment evolution over 12 months: double-blind randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. ; 161(2):202208.Faerstein, Eduardo, Moyses Szkio. 2013. Risk Factors For Uterine Leiomyoma: A Practice Based Case Control Study Atherogenic Risk Factors and Potential Sources of Uterine Leiomyomas. Amerika : American Journal of EpidemiologyFiscella K, Eisinger SH, Meldrum S, Feng C, Fisher SG, Guzick DS. 2006. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size. A randomized controlled trial. Obstet Gynecol.108(6): 13811387.Flake, G.P., J. Anderson, and D. Dixon. 2003. Etiology and Pathogenesis of Uterine Leiomyomas: a Review. Environmental Health Perspectives. 111 (8): 1037-1041.Hadibroto, Budi R. 2010. Mioma Uteri. Medan : Departemen Obstetri dan Ginekologi FK USU.Jarrett, Renne Buynton, Janet Rich Edward. 2003. A prospective study of Hypertention and Risk of Uterine Leimyomata. Amerika : American Journal Of EpidemiologyKing, A.E., F. Collins, T. Klonisch, J.M. Sallenave, H.O.D. Critchley, and P.T.K. Saunders. 2010. An Additive Interaction between The NFB and Estrogen Receptor Signaling Pathways in Human Endometrial Epithelial Cells. Human Reproduction. 25 (2):510-518Medilcare, Veronicha, Lakshmi Rao. 2011. The Genetic Base Of Uterine Fibroid. India : Jreprod Infertil.Montgomery, B.E., G.S. Daum, and C.J. Dunton. 2004. Endometrial Hyperplasia: A Review. Obstetrical and Gynecological Survey. 59 (5): 368-378.Moutsatsou, P., E. Kassi, G. Creatsas, S. Coulocheri, K. Scheller, and C.E.Sekeris.1998. Detection of Oestrogen Receptor Variants in Endometrium, Miometrium,Leiomyoma, and Peripheral Blood Mononuclear Cells: Comparison to Variants Present in Breast Cancer. Journal of Cancer Research and Clinical Oncology. 124 (9):478484.Mutter, G.L., and J.P.A. Baak. 2005. EIN & WHO 94. Journal of Clinical Pathology. 58: 16. Novak, Berek, S. Jonathan. 2011. Berek and Novaks Gynecology. Inggris : Lippincolt Wiliam & Wilkins.Parker, W.H. 2007. Etiology, Symptomatology, and Diagnosis of Uterine Myomas. American Society for Reproductive Medicine. 87 (4): 725-733.Prawirohardjo, Sarwono. 2010. Ilmu Kebidanan. Jakarta: Yayasan Bina Pustaka Sarwono PrawirohardjoRodin, RG., L. Rosenberg. 2012. Hypertension and Risk of Uterine Leiomyomata in US Black Women. Boston : Stone Epidemiology of Boston UniversitySchwartz, S.M. 2001. Studying the Epidemiology of Uterine Leiomyomata: Past, Present, and Future. American Journal of Epidemiology. 153(1): 27-29.Sutoto, M.S.G. 2007. Tumor Jinak pada Alat Genital. Hal. 338. Dalam : H. Wiknjosastro,A.B. Saifuddin dan T. Rachimhadi (Eds.), Ilmu Kandungan. Yayasan Bina Pustaka Sarwono Prawirohardjo, Jakarta.Tjay, Tan Hoan, Kirana Rahardja. 2010. Obat-Obat Penting. Jakarta : Penerbit PT Elex Media Komputindo Kelompok Kompas GramediaWHO. 2006. Obesity and Overweight. Retrieved April5, 2013, from http://www.who.int/mediacentre/factsheets/fs311/en/index.html.Wise, Lauren A., Julie R. Palmer. 2004. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African and American Women : A Prospective Study. Amerika : American Journal of Epidemiology.1